After capital expenditures and dividend payments have been made, Roche has generated excess free cash flow of almost $ 22 billion combined from 2012 - 2014, indicating the company is
a strong cash flow generator and the dividend is secure.
We're looking for companies that are undervalued — both on a discounted cash flow basis and versus peers — have strong growth potential, have a solid track record of creating economic profits for shareholders with reasonable risk, are
strong cash flow generators, have manageable financial leverage, and are currently showing bullish technical and momentum indicators.